GANCICLOVIR/ACYCLOVIR PROPHYLAXIS REDUCES THE INCIDENCE OF CYTOMEGALOVIRUS INFECTIONS IN PANCREAS TRANSPLANT RECIPIENTS

被引：0
|
作者：
HARLAND, RC
VERNON, WB
BUNZENDAHL, H
THOMPSON, JK
LAWRENCE, C
BOLLINGER, RR
机构：
来源：
TRANSPLANTATION PROCEEDINGS | 1994年 / 26卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：432 / 433
页数：2
相关论文
共 50 条
  • [31] INCIDENCE OF SURGICAL SITE INFECTIONS IN PANCREAS TRANSPLANT RECIPIENTS
    Ostaszewska, Agata
    Wszola, Michal
    Berman, Andrzej
    Gorski, Lukasz
    Serwanska-Swietek, Marta
    Trzebicki, Janusz
    Jozwik, Agnieszka
    Lipinska, Anna
    Krajewska, Monika
    Chmura, Andrzej
    Kwiatkowski, Artur
    TRANSPLANTATION, 2015, 99 (11) : S270 - S270
  • [32] Incidence of surgical site infections in pancreas transplant recipients
    Ostaszewska, Agata
    Wszola, Michal
    Berman, Andrzej
    Gorski, Lukasz
    Serwanska-Swietek, Marta
    Trzebicki, Janusz
    Jozwik, Agnieszka
    Lipinska, Anna
    Krajewska, Monika
    Chmura, Andrzej
    Kwiatkowski, Artur
    XENOTRANSPLANTATION, 2015, 22 : S164 - S164
  • [33] The use of sirolimus in ganciclovir-resistant cytomegalovirus infections in renal transplant recipients
    Ozaki, Kikumi Suzete
    Camara, Niels Olsen Saraiva
    Nogueira, Eliana
    Pereira, Mauricio Galvao
    Granato, Celso
    Melaragno, Claudio
    Camargo, Luis Fernando Aranha
    Pacheco-Silva, Alvaro
    CLINICAL TRANSPLANTATION, 2007, 21 (05) : 675 - 680
  • [34] Randomized controlled trial of oral ganciclovir versus oral acyclovir after induction with intravenous ganciclovir for long-term prophylaxis of cytomegalovirus disease in cytomegalovirus-seropositive liver transplant recipients
    Winston, DJ
    Busuttil, RW
    TRANSPLANTATION, 2003, 75 (02) : 229 - 233
  • [35] Intravenous ganciclovir prophylaxis for cytomegalovirus in heart, heart-lung, and lung transplant recipients
    Wreghitt, TG
    Abel, SJC
    McNeil, K
    Parameshwar, J
    Stewart, S
    Cary, N
    TRANSPLANT INTERNATIONAL, 1999, 12 (04) : 254 - 260
  • [36] Cytomegalovirus disease in high-risk transplant recipients despite ganciclovir or valganciclovir prophylaxis
    Akalin, E
    Sehgal, V
    Ames, S
    Hossain, S
    Daly, L
    Barbara, M
    Bromberg, JS
    AMERICAN JOURNAL OF TRANSPLANTATION, 2003, 3 (06) : 731 - 735
  • [37] Comparison of valganciclovir and oral ganciclovir for cytomegalovirus prophylaxis in solid organ transplant recipients.
    Kraman, AA
    Hardwick, LL
    Filo, RS
    Govani, MV
    Milgrom, ML
    Tector, AJ
    Pescovitz, MD
    PHARMACOTHERAPY, 2002, 22 (10): : 1370 - 1370
  • [38] Oral ganciclovir prophylaxis of cytomegalovirus (CMV) disease in pediatric renal transplant recipients.
    Feneberg, R
    Weber, LT
    Fickenscher, H
    Toenshoff, B
    PEDIATRIC TRANSPLANTATION, 2005, 9 : 118 - 118
  • [39] GANCICLOVIR IN CYTOMEGALOVIRUS PROPHYLAXIS IN HIGH-RISK PEDIATRIC RENAL-TRANSPLANT RECIPIENTS
    PROKURAT, S
    DRABIK, E
    GRENDA, R
    VOGT, E
    TRANSPLANTATION PROCEEDINGS, 1993, 25 (04) : 2577 - 2577
  • [40] Dosing of intravenous ganciclovir for the prophylaxis and treatment of cytomegalovirus infection in solid organ transplant recipients
    Fishman, JA
    Doran, MT
    Volpicelli, SA
    Cosimi, AB
    Flood, JG
    Rubin, RH
    TRANSPLANTATION, 2000, 69 (03) : 389 - 394
12345